Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin and Gastric Emptying in Stroke Patients Undergoing Mechanical Thrombectomy
2023-508120-35-00Phase 4Completed
- Sponsor
- Hôpital Foch
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of erythromycin in ischemic stroke (2 arms), sponsored by Hôpital Foch. Primary endpoint: Percentage reduction in antral surface area between initial and post-thrombectomy antral ultrasound. Started Feb 2024; status: completed.
02
Drugs
erythromycin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2023-508120-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508120-35-00.